Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies

Steven Johnson, Stephen Connelly, Ian A. Wilson, Jeffery W. Kelly

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Transthyretin (TTR) amyloidogenesis inhibitors are typically composed of two aromatic rings and a linker. We have previously established optimal structures for one aromatic ring and the linker. Herein, we employ a suboptimal linker and an optimal aryl-X substructure to rank order the desirability of aryl-Z substructures-using a library of 56 N-(3,5-dibromo-4-hydroxyphenyl) benzamides. Coconsideration of amyloid inhibition potency and ex vivo plasma TTR binding selectivity data reveal that 2,6, 2,5, 2, 3,4,5, and 3,5 substituted aryls bearing small substituents generate the most potent and selective inhibitors, in descending order. These benzamides generally lack undesirable thyroid hormone receptor binding and COX-1 inhibition activity. Three high-resolution TTR • inhibitor crystal structures (1.31-1.35 Å) provide insight into why these inhibitors are potent and selective, enabling future structure-based design of TTR kinetic stabilizers.

Original languageEnglish (US)
Pages (from-to)1115-1125
Number of pages11
JournalJournal of Medicinal Chemistry
Volume52
Issue number4
DOIs
StatePublished - Feb 26 2009
Externally publishedYes

Fingerprint

Prealbumin
Benzamides
Thyroid Hormone Receptors
Amyloid
Libraries

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. / Johnson, Steven; Connelly, Stephen; Wilson, Ian A.; Kelly, Jeffery W.

In: Journal of Medicinal Chemistry, Vol. 52, No. 4, 26.02.2009, p. 1115-1125.

Research output: Contribution to journalArticle

@article{0df82f728d69470887a6b1503df3740f,
title = "Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies",
abstract = "Transthyretin (TTR) amyloidogenesis inhibitors are typically composed of two aromatic rings and a linker. We have previously established optimal structures for one aromatic ring and the linker. Herein, we employ a suboptimal linker and an optimal aryl-X substructure to rank order the desirability of aryl-Z substructures-using a library of 56 N-(3,5-dibromo-4-hydroxyphenyl) benzamides. Coconsideration of amyloid inhibition potency and ex vivo plasma TTR binding selectivity data reveal that 2,6, 2,5, 2, 3,4,5, and 3,5 substituted aryls bearing small substituents generate the most potent and selective inhibitors, in descending order. These benzamides generally lack undesirable thyroid hormone receptor binding and COX-1 inhibition activity. Three high-resolution TTR • inhibitor crystal structures (1.31-1.35 {\AA}) provide insight into why these inhibitors are potent and selective, enabling future structure-based design of TTR kinetic stabilizers.",
author = "Steven Johnson and Stephen Connelly and Wilson, {Ian A.} and Kelly, {Jeffery W.}",
year = "2009",
month = "2",
day = "26",
doi = "10.1021/jm801347s",
language = "English (US)",
volume = "52",
pages = "1115--1125",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies

AU - Johnson, Steven

AU - Connelly, Stephen

AU - Wilson, Ian A.

AU - Kelly, Jeffery W.

PY - 2009/2/26

Y1 - 2009/2/26

N2 - Transthyretin (TTR) amyloidogenesis inhibitors are typically composed of two aromatic rings and a linker. We have previously established optimal structures for one aromatic ring and the linker. Herein, we employ a suboptimal linker and an optimal aryl-X substructure to rank order the desirability of aryl-Z substructures-using a library of 56 N-(3,5-dibromo-4-hydroxyphenyl) benzamides. Coconsideration of amyloid inhibition potency and ex vivo plasma TTR binding selectivity data reveal that 2,6, 2,5, 2, 3,4,5, and 3,5 substituted aryls bearing small substituents generate the most potent and selective inhibitors, in descending order. These benzamides generally lack undesirable thyroid hormone receptor binding and COX-1 inhibition activity. Three high-resolution TTR • inhibitor crystal structures (1.31-1.35 Å) provide insight into why these inhibitors are potent and selective, enabling future structure-based design of TTR kinetic stabilizers.

AB - Transthyretin (TTR) amyloidogenesis inhibitors are typically composed of two aromatic rings and a linker. We have previously established optimal structures for one aromatic ring and the linker. Herein, we employ a suboptimal linker and an optimal aryl-X substructure to rank order the desirability of aryl-Z substructures-using a library of 56 N-(3,5-dibromo-4-hydroxyphenyl) benzamides. Coconsideration of amyloid inhibition potency and ex vivo plasma TTR binding selectivity data reveal that 2,6, 2,5, 2, 3,4,5, and 3,5 substituted aryls bearing small substituents generate the most potent and selective inhibitors, in descending order. These benzamides generally lack undesirable thyroid hormone receptor binding and COX-1 inhibition activity. Three high-resolution TTR • inhibitor crystal structures (1.31-1.35 Å) provide insight into why these inhibitors are potent and selective, enabling future structure-based design of TTR kinetic stabilizers.

UR - http://www.scopus.com/inward/record.url?scp=64349108312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64349108312&partnerID=8YFLogxK

U2 - 10.1021/jm801347s

DO - 10.1021/jm801347s

M3 - Article

VL - 52

SP - 1115

EP - 1125

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 4

ER -